Product Information
ALLOPURINOL 300 MG TABLET is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.0546 per EA under NDC 70710121001. Its NADAC has been published 415 times since Sep 12, 2018.
FDA first approved this application on Oct 12, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Allopurinol market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
300 mg/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
70710121001
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ALLOPURINOLApproval Type
Generic (ANDA)
FDA Application
ANDA210117FDA Approved
10/12/2017
TE Code
AB
On Market Since
2/8/2018
Pharmacological Classes
Price Statistics
The NADAC for ALLOPURINOL 300 MG TABLET has been published 415 times since Sep 12, 2018, and over the history we have for it it has declined 63.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0546 per EA |
|---|---|
| All-time high | $0.1502 (Sep 12, 2018) |
| All-time low | $0.0546 (Aug 19, 2026) |
| 52-week high | $0.0674 |
| 52-week low | $0.0546 |
| Median price | $0.0811 |
| Average price | $0.0861 |
| Largest weekly change | -17.0% (Nov 20, 2024) |
| Weeks tracked | 415 |
| Tracking since | Sep 12, 2018 |
Generic Alternatives
The matcher finds 11 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ALLOPURINOL 300 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ALLOPURINOL 300 MG TABLET, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.0546 per EA (NDC 70710121001), effective Aug 19, 2026.
How has the price of ALLOPURINOL 300 MG TABLET changed over time?
Over the history we have for it, the NADAC for ALLOPURINOL 300 MG TABLET has declined 63.6%. It has been tracked across 415 weekly CMS publications since Sep 12, 2018.
What are the highest and lowest recorded NADAC prices for ALLOPURINOL 300 MG TABLET?
Since Sep 12, 2018, the NADAC for ALLOPURINOL 300 MG TABLET has ranged from a low of $0.0546 (Aug 19, 2026) to a high of $0.1502 (Sep 12, 2018), with a median of $0.0811 per EA.
Are there cheaper alternatives to ALLOPURINOL 300 MG TABLET?
11 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ALLOPURINOL 300 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures ALLOPURINOL 300 MG TABLET?
ALLOPURINOL 300 MG TABLET (NDC 70710121001) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.